C4 Therapeutics Announces FDA Orphan Drug Designation for CFT745CCCC: C4 Therapeutics, Inc. 2021-08-11 16:01:00 C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma Longby RocketTickers1